St. Jude Research on Twitter: "Dr. Thomas E. Merchant discusses the incidence of the brain tumor craniopharyngioma. Watch on @OncLive. https://t.co/2mr8ritRMg #RareDiseaseDay https://t.co/v8E5c8C4Jj" / Twitter
Leah Buletti » Cancer Center » UF Health Cancer Center » University of Florida
Neeraj Agarwal, MD, FASCO on Twitter: "Mitomycin gel receives FDA approval today as the 1st drug therapy for low grade upper tract urothelial carcinoma: Based on 58% CR noted in the OLYMPUS
OncLive TV | Page 526
OncLive TV
OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Maria Krevvata on LinkedIn: Dr. Garfall of the FDA Approval of Teclistamab in Relapsed/Refractory…
OncLive.com on Twitter: "What is the surgical approach for patients with HER2-positive breast cancer? #bcsm #bcher https://t.co/wHWRAuAZXK https://t.co/3ZGvvo62BF" / Twitter
Dr. Van Rhee on Future Research Directions for CAR T-Cell Therapy in Multiple Myeloma | UAMS Health
OncLive - Clinical Oncology News, Cancer Expert Insights
OncLiveTV - YouTube
Dr. Ruddy on the Use of GnRH Agonists in Breast Cancer | WATCH: Kathryn Ruddy, MD, discusses the use of GnRH agonists in breast cancer. https://bit.ly/3sp1JmB | By OncLive | Facebook
OncLive TV Releases 2 More Videos in Neuroendocrine Tumors Series - Carcinoid Cancer Foundation
OncLiveTV - YouTube
OncLive - Clinical Oncology News, Cancer Expert Insights
OncLiveTV - YouTube
Trish Alexander - Key Account Manager, Oncology - Pfizer | LinkedIn
Weill Cornell Genitourinary Cancer Program - One-minute rundown: In this OncLive video, Dr. Scott Tagawa discusses the benefits of radium-223 dichloride (Xofigo) in prostate cancer. https://bit.ly/3BB1W98 | Facebook
The Angeles Clinic and Research Institute - Omid Hamid, MD, chief, translational research and immunotherapy, discusses using immune therapy to treat patients with melanoma. http://www.onclive.com/onclive-tv/dr-hamid-on-immune-therapy-in-melanoma | Facebook
OncLive TV | Clinical Oncology News & Insights | OncLive
How Alexa can speak more like you
Paolo Tarantino en LinkedIn: Dr. Tarantino on the Impact of the DESTINY-Breast04 Trial in HER2-Low…
OncLive (onclive) - Profile | Pinterest
OncLive® On Air on Apple Podcasts
Dr. Vaena on the Importance of Risk Stratification in Prostate Cancer - West Cancer Center
Dr. Porter on Potential Sequencing With ADCs and TKIs in HER2+ Lung Cancer - West Cancer Center
